Eli Lilly and Company (“Lilly”), a global leader in pharmaceuticals and innovation, has announced the establishment of a state-of-the-art global capability centre in Hyderabad, India. The new centre, named Lilly Capability Centre India (LCCI) Hyderabad, is slated to open in mid-2025 and represents a significant step in Lilly’s global expansion efforts.
Strengthening Lilly’s Digital Strategy
LCCI Hyderabad will play a pivotal role in strengthening Lilly’s digital strategy and service delivery. With plans to hire over 1,000 highly skilled professionals, the centre will focus on cutting-edge domains such as automation, artificial intelligence (AI), software product engineering, and cloud computing. These advancements are aimed at delivering innovative technology solutions that meet the dynamic needs of Lilly’s global operations.
This initiative follows the success of Lilly’s first capability centre in Bengaluru, established in 2016, which has already demonstrated the value of leveraging India’s technological talent pool. Manish Arora, Managing Director of LCCI Hyderabad, emphasized the critical role that India’s workforce plays in driving centralized, scalable solutions for Lilly’s global business.
“Our teams in India play a pivotal role in driving Lilly’s global business support with centralized, scalable solutions. LCCI Hyderabad will enhance our technical capabilities, enabling us to better meet growing business demands, fully leverage technology in our operations, and further expand our presence in India,” said Arora.
A Milestone for Hyderabad’s Growing Innovation Hub
The choice of Hyderabad for Lilly’s new centre underscores the city’s burgeoning reputation as a hub for healthcare innovation and technological expertise. Telangana’s Minister for Information Technology, Electronics & Communications, Industries & Commerce, and Legislative Affairs, Duddilla Sridhar Babu, expressed his support for Lilly’s investment in the region.
“We are pleased to welcome Lilly’s new global capability centre to Hyderabad. This investment underscores Hyderabad’s growing reputation as a hub for healthcare innovation and talent. We fully support Lilly’s vision to make life better for people around the world and are confident that this centre will contribute significantly to the local economy and help improve health globally,” Babu said.
Hyderabad’s longstanding legacy in fostering technology-driven enterprises and healthcare innovation makes it an ideal location for this new venture. The city continues to attract global corporations seeking to leverage its rich talent pool and supportive ecosystem.
Driving Innovation with Advanced Technologies
Diogo Rau, Executive Vice President and Chief Information and Digital Officer of Lilly, highlighted the strategic importance of LCCI Hyderabad. “Hyderabad is a hub of innovation with decades of history in technology, and we are excited to announce plans to launch a new centre here. We will bring together talented technology professionals who want to make life better for people around the world,” Rau stated.
The centre aims to integrate engineers from various disciplines to develop advanced technologies and tools designed to tackle some of the most significant health challenges globally. By unlocking new technological advancements and leveraging data insights, LCCI Hyderabad will accelerate the delivery of next-generation medicines to patients worldwide.
Expanding Employment Opportunities
Lilly plans to employ approximately 1,000 to 1,500 highly skilled professionals, including technology engineers and data scientists, for its Hyderabad centre. Recruitment for these roles has already commenced, underscoring Lilly’s commitment to fostering local talent. The hiring strategy will prioritize expertise in AI, cloud computing, data analytics, and software engineering, aligning with the company’s vision to harness cutting-edge technology for improved healthcare outcomes.
A Vision for the Future
The establishment of LCCI Hyderabad signifies Lilly’s dedication to addressing global health challenges through innovation and collaboration. By leveraging India’s technological expertise and Hyderabad’s thriving innovation ecosystem, the new centre will contribute to Lilly’s mission of making life better for people worldwide.
As the global pharmaceutical industry continues to evolve, initiatives like LCCI Hyderabad represent a critical investment in technological advancement and talent development. The centre’s operational launch in 2025 will undoubtedly mark a milestone in Lilly’s journey towards redefining healthcare innovation.
